191 related articles for article (PubMed ID: 20556608)
21. Expression of p16 protein and cyclin D1 in periampullary carcinomas.
Tuncer E; Türk NS; Arici S; Düzcan SE; Demirkan NC
Turk Patoloji Derg; 2011 Jan; 27(1):17-22. PubMed ID: 21469422
[TBL] [Abstract][Full Text] [Related]
22. The correlation of cortactin and fascin-1 expression with clinicopathological parameters in pancreatic and ampulla of Vater adenocarcinoma.
Tsai WC; Lin CK; Lee HS; Gao HW; Nieh S; Chan DC; Jin JS
APMIS; 2013 Mar; 121(3):171-81. PubMed ID: 23030700
[TBL] [Abstract][Full Text] [Related]
23. Prognostic indicators following curative pancreatoduodenectomy for pancreatic carcinoma: A retrospective multivariate analysis of a single centre experience.
Petrou A; Soonawalla Z; Silva MA; Manzelli A; Moris D; Tabet PP; Friend P
J BUON; 2016; 21(4):874-882. PubMed ID: 27685908
[TBL] [Abstract][Full Text] [Related]
24. Predictors of survival in periampullary cancers following pancreaticoduodenectomy.
Hatzaras I; George N; Muscarella P; Melvin WS; Ellison EC; Bloomston M
Ann Surg Oncol; 2010 Apr; 17(4):991-7. PubMed ID: 20108122
[TBL] [Abstract][Full Text] [Related]
25. Intestinal-type of differentiation predicts favourable overall survival: confirmatory clinicopathological analysis of 198 periampullary adenocarcinomas of pancreatic, biliary, ampullary and duodenal origin.
Bronsert P; Kohler I; Werner M; Makowiec F; Kuesters S; Hoeppner J; Hopt UT; Keck T; Bausch D; Wellner UF
BMC Cancer; 2013 Sep; 13():428. PubMed ID: 24053229
[TBL] [Abstract][Full Text] [Related]
26. Distinguishing pancreatic carcinoma from other periampullary carcinomas by analysis of mutations in the Kirsten-ras oncogene.
Motojima K; Tsunoda T; Kanematsu T; Nagata Y; Urano T; Shiku H
Ann Surg; 1991 Dec; 214(6):657-62. PubMed ID: 1741644
[TBL] [Abstract][Full Text] [Related]
27. Cytokeratin-positive cells in the bone marrow from patients with pancreatic, periampullary malignancy and benign pancreatic disease show no prognostic information.
Hugenschmidt H; Labori KJ; Brunborg C; Verbeke CS; Seeberg LT; Bendigtsen Schirmer C; Renolen A; Borgen E; Naume B; Wiedswang G
BMC Cancer; 2020 Nov; 20(1):1107. PubMed ID: 33198661
[TBL] [Abstract][Full Text] [Related]
28. p53 accumulation confers prognostic information in resectable adenocarcinomas with ductal but not with intestinal differentiation in the pancreatic head.
Bergan A; Gladhaug IP; Schjolberg A; Bergan AB; Clausen OP
Int J Oncol; 2000 Nov; 17(5):921-6. PubMed ID: 11029493
[TBL] [Abstract][Full Text] [Related]
29. Impact of lymph node ratio on survival in patients with pancreatic and periampullary cancer.
Tol JA; Brosens LA; van Dieren S; van Gulik TM; Busch OR; Besselink MG; Gouma DJ
Br J Surg; 2015 Feb; 102(3):237-45. PubMed ID: 25529117
[TBL] [Abstract][Full Text] [Related]
30. [Results of pancreaticoduodenectomy in the treatment of periampullary tumors].
Norero E; Viñuela E; Báez S; Martínez C; Reyes J; Kusanovic R; Sanhueza M; Aguayo G; Calvo A; Mege RM; Caracci M; Díaz A
Rev Med Chil; 2011 Aug; 139(8):1015-24. PubMed ID: 22215331
[TBL] [Abstract][Full Text] [Related]
31. [Result of p53, ki-67 protein expression in cholangiocarcinoma with in situ hybridization and immunohistochemistry methods].
Wang X; Zhang J; Chen J
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):57-60. PubMed ID: 12903495
[TBL] [Abstract][Full Text] [Related]
32. Reclassification of tumour origin in resected periampullary adenocarcinomas reveals underestimation of distal bile duct cancer.
Pomianowska E; Grzyb K; Westgaard A; Clausen OP; Gladhaug IP
Eur J Surg Oncol; 2012 Nov; 38(11):1043-50. PubMed ID: 22883964
[TBL] [Abstract][Full Text] [Related]
33. Does lymph node ratio impact survival in resected periampullary malignancies?
Hurtuk MG; Hughes C; Shoup M; Aranha GV
Am J Surg; 2009 Mar; 197(3):348-52. PubMed ID: 19245913
[TBL] [Abstract][Full Text] [Related]
34. Effect of Pancreatic Fistula on Recurrence and Long-Term Prognosis of Periampullary Adenocarcinomas after Pancreaticoduodenectomy.
Serrano PE; Kim D; Kim PT; Greig PD; Moulton CA; Gallinger S; Wei AC; Cleary SP
Am Surg; 2016 Dec; 82(12):1187-1195. PubMed ID: 28234183
[TBL] [Abstract][Full Text] [Related]
35. Pylorus-preserving pancreatoduodenectomy. Is it an adequate cancer operation.
Tsao JI; Rossi RL; Lowell JA
Arch Surg; 1994 Apr; 129(4):405-12. PubMed ID: 7908796
[TBL] [Abstract][Full Text] [Related]
36. Distribution and pathological features of pancreatic, ampullary, biliary and duodenal cancers resected with pancreaticoduodenectomy.
Chandrasegaram MD; Chiam SC; Chen JW; Khalid A; Mittinty ML; Neo EL; Tan CP; Dolan PM; Brooke-Smith ME; Kanhere H; Worthley CS
World J Surg Oncol; 2015 Feb; 13():85. PubMed ID: 25890023
[TBL] [Abstract][Full Text] [Related]
37. Expression of gastric mucin MUC5AC and gastric transcription factor SOX2 in ampulla of vater adenocarcinoma: comparison between expression patterns and histologic subtypes.
Sanada Y; Yoshida K; Konishi K; Oeda M; Ohara M; Tsutani Y
Oncol Rep; 2006 May; 15(5):1157-61. PubMed ID: 16596179
[TBL] [Abstract][Full Text] [Related]
38. Carcinoid tumors of the duodenum and ampulla of vater: a clinicomorphologic, immunohistochemical, and cell kinetic comparison.
Bornstein-Quevedo L; Gamboa-Domínguez A
Hum Pathol; 2001 Nov; 32(11):1252-6. PubMed ID: 11727266
[TBL] [Abstract][Full Text] [Related]
39. Advances in Molecular Pathology and Treatment of Periampullary Cancers.
Chandrasegaram MD; Chen JW; Price TJ; Zalcberg J; Sjoquist K; Merrett ND
Pancreas; 2016 Jan; 45(1):32-9. PubMed ID: 26348463
[TBL] [Abstract][Full Text] [Related]
40. Bile duct expression of pancreatic and duodenal homeobox 1 in perihilar cholangiocarcinogenesis.
Igarashi S; Matsubara T; Harada K; Ikeda H; Sato Y; Sasaki M; Matsui O; Nakanuma Y
Histopathology; 2012 Aug; 61(2):266-76. PubMed ID: 22594685
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
